Cargando…
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097343/ https://www.ncbi.nlm.nih.gov/pubmed/30115067 http://dx.doi.org/10.1186/s13054-018-2093-y |
| _version_ | 1783348284634431488 |
|---|---|
| author | Honore, Patrick M. De Bels, David Preseau, Thierry Redant, Sebastien Spapen, Herbert D. |
| author_facet | Honore, Patrick M. De Bels, David Preseau, Thierry Redant, Sebastien Spapen, Herbert D. |
| author_sort | Honore, Patrick M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6097343 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60973432018-08-20 Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? Honore, Patrick M. De Bels, David Preseau, Thierry Redant, Sebastien Spapen, Herbert D. Crit Care Letter BioMed Central 2018-08-17 /pmc/articles/PMC6097343/ /pubmed/30115067 http://dx.doi.org/10.1186/s13054-018-2093-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Honore, Patrick M. De Bels, David Preseau, Thierry Redant, Sebastien Spapen, Herbert D. Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| title | Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| title_full | Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| title_fullStr | Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| title_full_unstemmed | Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| title_short | Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| title_sort | efficacy of polymyxin b hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097343/ https://www.ncbi.nlm.nih.gov/pubmed/30115067 http://dx.doi.org/10.1186/s13054-018-2093-y |
| work_keys_str_mv | AT honorepatrickm efficacyofpolymyxinbhemoperfusioninandbeyondsepticshockisanendotoxinseverityscoreneeded AT debelsdavid efficacyofpolymyxinbhemoperfusioninandbeyondsepticshockisanendotoxinseverityscoreneeded AT preseauthierry efficacyofpolymyxinbhemoperfusioninandbeyondsepticshockisanendotoxinseverityscoreneeded AT redantsebastien efficacyofpolymyxinbhemoperfusioninandbeyondsepticshockisanendotoxinseverityscoreneeded AT spapenherbertd efficacyofpolymyxinbhemoperfusioninandbeyondsepticshockisanendotoxinseverityscoreneeded |